Stay updated on Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial

Sign up to get notified when there's something new on the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed notices about government funding lapse and the earlier Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:21:21.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and the NIH Clinical Center being open, with guidance to cc.nih.gov and opm.gov, and updated the page version from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:33:15.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A glossary toggle was added; minor wording/capitalization tweaks were applied to the QC criteria phrasing and FEAR Act data, and the revision label updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:11:09.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added and v3.3.3 removed; this is a minor page update with no impact on core content or study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:58:46.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Adds a centralized 'Locations' section listing study sites by state (Arizona, California, Florida, Louisiana, Massachusetts, Michigan, New York, North Carolina, Texas, Utah) and updates the revision to v3.3.3. Removes the separate per-state location subsections (Arizona Locations, California Locations, etc.) in favor of the consolidated list.
    Difference
    1%
    Check dated 2025-12-23T09:22:53.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown, replacing v3.3.1, as a minor UI/version update that does not alter the study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:23.000Z thumbnail image

Stay in the know with updates to Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety and Tolerability of VK2809 in Hypercholesterolemia Clinical Trial page.